August 7, 2026
Quantum BioPharma’s Dual Strategy Targets Neurological Health with MS Drug and Alcohol Supplement
August 7, 2026
Spanish Case of Pork Tapeworm Mimicking Brain Cancer Underscores Diagnostic Challenges and Need for New Treatments
August 6, 2026
Keep A Breast Foundation Unveils 2026 High Desert Collection to Spark Conversations on Breast Health
August 6, 2026
Liquid Biopsy Could Predict Immunotherapy Response in Advanced Lung Cancer, Study Suggests
August 5, 2026
Onco-Innovations Integrates AI, Nanotech, and Targeted Therapy in New Cancer Drug Development
August 5, 2026
More than 3,000 Hospitals Recognized for Commitment to High-Quality Cardiovascular Care
August 3, 2026
Independent Research Highlights Potential for Broader Filovirus Vaccines, Supporting GeoVax’s MVA Platform
July 30, 2026
VERAXA Biotech Appoints Dr. Christoph Erkel as CSO to Advance BiTAC Cancer Therapy Platform
July 30, 2026
Dr. Lee Newcomer, Author of ‘UNMASKED,’ Signs With Creative Management Partners for Book Promotion
July 29, 2026
VERAXA Biotech Expands Patent Portfolio to Protect Next-Generation Cancer Therapy Platforms
July 29, 2026
VERAXA Biotech Appoints Dr. Christoph Erkel as Chief Scientific Officer to Advance BiTAC(R) Cancer Therapy Platform
July 27, 2026
Onco-Innovations Advances ONC010 Toward Clinical Trials with Manufacturing and Partnership Milestones
July 24, 2026
VERAXA Biotech Appoints Christoph Erkel as Chief Scientific Officer, Bolstering Solid Tumor Pipeline
July 23, 2026
VERAXA Biotech Receives Regulatory Support from Germany’s Paul-Ehrlich-Institute for BiTAC®-TCE Platform
July 23, 2026
Recent Disease Outbreaks Expose Critical Gaps in U.S. Public Health Systems, Expert Says
July 23, 2026
Lantern Pharma Receives U.S. Patent Allowance for LP-184 Biomarker-Based Treatment Methods
July 23, 2026
VERAXA Biotech Appoints Christoph Erkel as Chief Scientific Officer to Lead BiTAC Platform Development
July 22, 2026
Kairos Pharma Collaborates with Bayer to Test ENV-105 in Combination with Xofigo for Advanced Prostate Cancer
July 22, 2026
VERAXA Biotech Receives Positive Regulatory Guidance for BiTAC-TCE Platform from German Authority
July 21, 2026
Greenwich LifeSciences Advances Phase 3 Breast Cancer Immunotherapy Trial with Expanded Enrollment
July 21, 2026
Quantum BioPharma Targets Multiple Sclerosis and Alcohol Intoxication with Novel Pipeline
July 21, 2026
Michael Svestka, MD, FACS, Named 2026 Castle Connolly Top Doctor for Hernia Surgery Expertise
July 20, 2026
World Brain Day Highlights New Initiative to Translate Brain Health Research into Daily Habits
July 20, 2026
VERAXA Biotech Receives Regulatory Feedback Advancing BiTAC-TCE Cancer Therapy Toward Clinical Development
July 18, 2026
Cayenne Wellness Center Unveils ‘Scar Stories’ Art Exhibit Highlighting Sickle Cell Warriors
